Optimizing glycoprotein IIb/IIIa inhibition: lessons from recent randomized controlled trials. [electronic resource]
Producer: 20030123Description: 338-45 p. digitalISSN:- 1444-0903
- Abciximab
- Acute Disease
- Angina, Unstable -- drug therapy
- Angioplasty, Balloon, Coronary
- Antibodies, Monoclonal -- pharmacology
- Dose-Response Relationship, Drug
- Drug Administration Schedule
- Eptifibatide
- Humans
- Immunoglobulin Fab Fragments -- pharmacology
- Myocardial Infarction -- drug therapy
- Peptides -- pharmacology
- Platelet Aggregation Inhibitors -- administration & dosage
- Platelet Glycoprotein GPIIb-IIIa Complex -- antagonists & inhibitors
- Randomized Controlled Trials as Topic
- Risk Assessment
- Risk Factors
- Syndrome
- Time Factors
- Tirofiban
- Treatment Outcome
- Tyrosine -- analogs & derivatives
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.